SUMMARY The action of pure, natural secretin on the pancreatic secretion of enzymes was investigated in six patients with external transduodenal drainage of the main pancreatic duct performed after biliary tract surgery. Secretin infused for five successive 50 minute periods at increasing doses of 0*03, 0 1, 0-3, 0.9 and 2.7 clinical units (CU)/kg/h, produced a dose dependent increase in protein and lipase output. A weak but significant (p<0.02) increase of enzyme output above the fasting level was already observed with the lowest dose. The maximal output of protein and lipase, observed with the highest dose of secretin infused, corresponded to about 50% of that induced by maximal doses of cerulein (100 ng/kg/h) plus secretin (1 CU/kg/h). As far as bicarbonate is concerned, the lowest dose of secretin (0.03 CU/kg/h) significantly (p<0-001) stimulated bicarbonate output. The dose of 0-9 CU/kg/h of secretin evoked a bicarbonate output of 526±49 ,mol/min; trebling the dose of secretin did not significantly increase the output of bicarbonate above this value. Increasing doses of secretin induced a dose related increase in calcium output. There was a close parallel between calcium and protein outputs, suggesting that the increase in calcium output reflected primarily an increase in the enzyme-associated fraction of pancreatic juice calcium. It is concluded that secretin stimulates pancreatic enzyme secretion in man probably by a direct action on the acinar cells.
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The stimulation of water and bicarbonate secretion has been long considered the only action of secretin on pancreatic secretion. In recent years, however, several in vivo and in vitro studies have reported that secretin can also stimulate pancreatic enzyme secretion in some animal species. -The influence of secretin on pancreatic enzyme secretion in man is not well defined. Most of the old studies dealing with this problem led to negative conclusions.
The rise in enzyme output observed by some investigators after secretin administration,9 10 was generally considered a consequence of a 'washout' of previously secreted enzymes by secretin stimulated flow of fluid through the duct system.6 10 The possibility that secretin might stimulate human pancreatic enzyme secretion was raised by Wormsley in 1968.11 In a study carried out by means of duodenal intubation, this investigator found that the pancreatic output of trypsin increased with increasing doses of secretin at low levels of stimulation, whereas supramaximal doses of secretin inhibited trypsin secretion. In this study, however, the majority of subjects received Boots secretin, which was contaminated with cholecystokinin,12 and only four subjects received the pure secretin preparation of Jorpes and Mutt. Moreover, these findings were not confirmed in a more recent study by Domschke et al13 who evaluated the effects of increasing doses of secretin on pure pancreatic juice collected by endoscopic cannulation of the papilla of Vater and failed to detect any significant effect of the hormone on pancreatic enzyme secretion. The present study was designed in an attempt to obtain more precise information on the action of secretin on pancreatic enzyme secretion in man. In order to avoid possible interferences of bile or other gastrointestinal secretions, the study was carried out directly on pure pancreatic juice.
Methods

PATIENTS
Six patients with no clinical history or biochemical signs of pancreatic disease gave informed consent to 867 participate in this study. They were five men and one woman, aged 41-68 years, mean 50 years. Their weights ranged from 50 to 75 kg, with a mean of 63 kg. The method for collecting pure pancreatic juice has been described previously. 4 15 The patients had transduodenal drainage of the main pancreatic duct performed after papillotomy and sphincteroplasty for common bile duct stones. The appearance of the pancreas at operation was normal in all patients. The drainage was not carried out specifically for the purpose of this study, but as a part of the therapeutic programme to prevent the formation of duodenal fistulae and postoperative acute pancreatitis.16
Polyethylene tubes provided with several additional holes in the intraductal portion were inserted into Wirsung's canal to a depth of about 3-4 cm and were tied to the duodenal wall by a stitch of catgut. Their diameter was accurately selected in each patient according to the calibre of the main pancreatic duct. After insertion of the tube, an intravenous injection of secretin, 0-5 CU/kg/h, was given to confirm the efficacy of the drainage and to exclude leakage of pancreatic juice around the cannula. Studies were performed in the morning after an overnight fast, and were started at least six days after the operation. It has been shown that pancreatic secretion is depressed during the first two to three days after the operation and returns to normal thereafter.14 16 In order to avoid the entry of acid into the duodenum, gastric juice was continuously aspirated by a nasogastric tube positioned before the study. Pancreatic juice was collected in ice chilled graduated tubes at 10 minute intervals. Initially, pancreatic juice was collected for five 10 minute periods to estimate the fasting secretion. Then, pure natural secretin (GIH Research Unit, Karolinska Institutet, Stockholm, Sweden) was infused into an arm vein for five successive 50 minute periods at the following increasing rates: 0-03, 0*1, 0-3, 0*9, and 2*7 clinical units (CU)/kg/h (equivalent to 2-8, 9.3, 28, 84, and 252 pmol/kg/h, respectively). Each dose of secretin was dissolved in 100 ml isotonic saline containing 03% human serum albumin. To assess pancreatic enzyme response to maximal stimulation, a second study was carried out on a separate day in five of the six subjects. In this study, an intravenous infusion of cerulein, at a maximal dose17 of 100 ng/kg/h, plus secretin, 1 Figure 1 shows pancreatic juice volume, bicarbonate concentration, and bicarbonate output during the last two 10 minute periods of each dose rate of secretin. The hormone produced a dose dependent increase in volume and bicarbonate output. A significant rise in pancreatic juice flow and bicarbonate output above the fasting level was already elicited with the lowest dose used (0.03 CU/kg/h). The maximal volume flow (4-32±0.46 ml/min) and bicarbonate output (569±59 ,mol/min) was observed during infusion of the highest dose of secretin used (2.7 CU/kg/h). The bicarbonate output observed with this dose of secretin, however, was not significantly higher than that attained with 0*9 CU/kg/h (526±49,umol/min).
The concentration of bicarbonate rose with increasing dose rates of secretin up to 0.3 CU/kg/h. At higher hormone doses the concentration declined while the volume continued to increase. Figure 2 shows the concentrations of protein, lipase, and calcium during the last two 10 minute periods of each dose rate of secretin. These parameters showed a parallel behaviour. In all subjects, the concentrations of protein, lipase, and calcium were greater in the fasting than in postsecretin collections. They were high in the first 10-20 minutes after starting secretin stimulation, likely reflecting a 'washout' phenomenon, and then fell rapidly to a plateau level when secretin stimulation was continued (Table) . In each subject, concentration levels declined slightly during infusions of secretin from the dose of 0-03 to the dose of 0.3 CU/kg/h, and then remained almost constant from the dose of 0-3 to that of 2-7 CU/kg/h. In analogy to concentrations, outputs of protein, lipase, and calcium (Fig. 3 ) also behaved in a parallel fashion. The infusion of the lowest dose of secretin (0.03 CU/kg/h) produced a weak but significant increase in enzyme (p<002) and calcium (p<0005) output above the fasting level. Increasing doses of secretin induced a dose related increase of these outputs. The mean maximal output of protein, lipase, and calcium, observed during the highest dose of secretin used (2-7 CU/kg/h), were 49%, 46%, and 54% of the protein, lipase, and calcium output, respectively, in response to a maximal dose of cerulein (100 ng/kg/h) combined with secretin (1 CU/kg/h). (mg/ml) 3. the concentration of both protein and lipase declined slightly or remained constant. It is unlikely that the increase in protein and lipase output seen in the present study was because of contamination with pancreozymin, as the secretin preparation used did not contain any trace of pancreozymin.21 Moreover, several comparative studies of the effects of natural and synthetic secretins on pancreatic secretion failed to show significant differences between the two preparations.1 [22] [23] [24] It is also highly unlikely that the increase in enzyme output was because of an indirect 'washout' phenomenon. In fact, each dose of secretin was infused at a constant rate for 50 minutes and the enzyme output measured during the last 20 minutes, when a steady state was attained after the early washout. Moreover, the stepwise increase of the infused secretin concentration brought about corresponding increases in enzyme output (during infusion of the last three doses of secretin, from 0 03 to 2-7 CU/kg/h, protein and lipase concentrations remained practically unchanged while the volume of pancreatic juice continued to rise). We interpret these data as an indication that secretin can act directly on the acinar cells to stimulate enzyme secretion. This possibility is supported also by several experimental findings, including the demonstration of the existence of specific receptors for secretin in the acinar cells,25 and the observation that secretin can potentiate cholecystokinin-stimulated enzyme secretion in vitro as well as in vivo.3 12 26 27 The results of this study confirm the observations of Wormsley, 11 The effect of secretin infusion on calcium secretion into pure human pancreatic juice had never been investigated up to now. With increasing doses of the hormone a close parallelism between calcium and protein was found, similar to that observed after cholecystokinin stimulation. 37 It is known that calcium is secreted into the pancreatic juice in two fractions, one associated with enzymes, and the other with the electrolyte component.38 39 Because of the parallel behaviour of calcium and protein secretion, it is likely that the increase in calcium output during infusions of secretin reflected primarily an increase of the enzyme associated fraction of pancreatic juice calcium.
In conclusion, the results of the present study indicate that, as in several animal species, secretin is able to increase pancreatic enzyme secretion in man. This effect is probably the result of a direct action exerted by the hormone on the acinar cells of the gland. 
